about
Development and characterization of a novel mAb against bilitranslocase - a new biomarker of renal carcinoma.Intestinal-mucosa anti-transglutaminase antibody assays to test for genetic gluten intolerance.Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease.Cross-sectional study of coeliac autoimmunity in a population of Vietnamese children.Gluten-dependent intestinal autoimmune response.Lack of evidence of rotavirus-dependent molecular mimicry as a trigger of coeliac disease.The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency.Fasting increases tobramycin oral absorption in micePrevalence of celiac disease in patients with severe food allergy.Serum anti-tissue transglutaminase antibodies detected during febrile illness may not be produced by the intestinal mucosa.Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches.Triticum monococcum in patients with celiac disease: a phase II open study on safety of prolonged daily administration.Anti-transglutaminase 6 Antibody Development in Children With Celiac Disease Correlates With Duration of Gluten Exposure.A Sensitive Electrochemiluminescence Immunosensor for Celiac Disease Diagnosis Based on Nanoelectrode Ensembles.Innate and adaptive immunity in self-reported nonceliac gluten sensitivity versus celiac disease.Potential use of MCR-ALS for the identification of coeliac-related biochemical changes in hyperspectral Raman maps from pediatric intestinal biopsiesA Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies
P50
Q30432428-4D68B318-98CD-406D-83AF-173C81A6C566Q34455608-AD644CD8-BEB0-47B6-826A-40E931920BE1Q36221213-74A22460-8EEA-40DC-BCD3-524649B4C297Q37027986-384D203A-CFD6-4FB6-B2C6-A9FAAC70A9FAQ38020986-3C40B077-2F74-4753-939A-A694D35FA4DDQ39466510-0B7357A4-E02C-4A0A-9C37-6FC56958BE08Q39571798-67621877-CABA-41BA-97EA-FF0B62DD8AEAQ39895437-8F74919E-FA1B-4614-B45F-DB1D0AF984B9Q40731479-F84891D9-73B7-46FB-84E9-42CAE27915ACQ41461439-7CB8EF08-4B4D-4A93-883F-3A9934BF0E8DQ43141414-044352A0-9DD3-43A5-9A6C-1AE72C668CAEQ47424425-F253D1F1-4905-4AEB-BD31-199DA8E7BB79Q50624556-7827FDF7-9CCE-467C-88A3-602CDAD501BCQ50913987-754EA040-CEEB-4DB4-BCA8-F8EA1A804F15Q53111211-AEC9A362-4B51-4732-8487-220204F940F6Q62545658-634850A5-97F9-4429-BF58-55B184EF5C7CQ91010033-A3469116-176C-4940-8A2B-940CC99ED6E5
P50
description
researcher ORCID ID = 0000-0003-4013-1630
@en
wetenschapper
@nl
name
Luigina De Leo
@ast
Luigina De Leo
@en
Luigina De Leo
@es
Luigina De Leo
@nl
type
label
Luigina De Leo
@ast
Luigina De Leo
@en
Luigina De Leo
@es
Luigina De Leo
@nl
prefLabel
Luigina De Leo
@ast
Luigina De Leo
@en
Luigina De Leo
@es
Luigina De Leo
@nl
P106
P1153
35758199800
57192215376
P31
P496
0000-0003-4013-1630